{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:25:27Z","timestamp":1783070727486,"version":"3.54.6"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hereditary haemorrhagic telangiectasia (HHT) is a multisystemic vascular dysplasia inherited as an autosomal dominant trait. Approximately 10 % of patients have cerebral vascular malformations, a proportion being cerebral arteriovenous malformations (AVMs) and fistulae that may lead to potentially devastating consequences in case of rupture. On the other hand, detection and treatment related-risks are not negligible, and immediate. While successful treatment can be undertaken in individual cases, current data do not support the treatment of unruptured AVMs, which also present a low risk of bleeding in HHT patients. Screening for these AVMs is therefore controversial.<\/jats:p><jats:p>Structured discussions, distinctions of different cerebrovascular abnormalities commonly grouped into an \u201cAVM\u201d bracket, and clear guidance by neurosurgical and neurointerventional radiology colleagues enabled the European Reference Network for Rare Vascular Disorders (VASCERN-HHT) to develop the following agreed Position Statement on cerebral screening:<\/jats:p><jats:p>1) First, we emphasise that neurological symptoms suggestive of cerebral AVMs in HHT patients should be investigated as in general neurological and emergency care practice. Similarly, if an AVM is found accidentally, management approaches should rely on expert discussions on a case-by-case basis and individual risk-benefit evaluation of all therapeutic possibilities for a specific lesion.<\/jats:p><jats:p>2) The current evidence base does not favour the treatment of unruptured cerebral AVMs, and therefore cannot be used to support widespread screening of asymptomatic HHT patients.<\/jats:p><jats:p>3) Individual situations encompass a wide range of personal, cultural and clinical states. In order to enable informed patient choice, and avoid conflicting advice, particularly arising from non-neurovascular interpretations of the evidence base, we suggest that all HHT patients should have the opportunity to discuss knowingly brain screening issues with their healthcare provider.<\/jats:p><jats:p>4) Any screening discussions in asymptomatic individuals should be preceded by informed pre-test review of the latest evidence regarding preventative and therapeutic efficacies of any interventions. The possibility of harm due to detection of, or intervention on, a vascular malformation that would not have necessarily caused any consequence in later life should be stated explicitly.<\/jats:p><jats:p>We consider this nuanced Position Statement provides a helpful, evidence-based framework for informed discussions between healthcare providers and patients in an emotionally charged area.<\/jats:p>","DOI":"10.1186\/s13023-020-01386-9","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T11:02:59Z","timestamp":1593428579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)"],"prefix":"10.1186","volume":"15","author":[{"given":"Omer F.","family":"Eker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Boccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Sure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Alicante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alsafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Coote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya","family":"Droege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette Dam","family":"Fialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryony","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujwal","family":"Kariholu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette D.","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lefroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro M.","family":"Lenato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Jurgen","family":"Mager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels H.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pagella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco C.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sabb\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Suppressa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille M.","family":"Toerring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ugolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Buscarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dupuis-Girod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L.","family":"Shovlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"1386_CR1","unstructured":"Hereditary haemorrhagic telangiectasia, available at www.orpha.net\/consor\/www\/cgi-bin\/OC_Exp.php?lng=EN&Expert=774 (accessed 10th Feb 2020)."},{"key":"1386_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2307\/1533331","volume":"44","author":"A Bideau","year":"1989","unstructured":"Bideau A, Plauchu H, Brunet G, Robert J. Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Population. 1989;44:3\u201322.","journal-title":"Population."},{"key":"1386_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","volume":"245","author":"AD Kjeldsen","year":"1999","unstructured":"Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med. 1999;245:31\u20139.","journal-title":"J Intern Med"},{"key":"1386_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/thoraxjnl-2013-203720","volume":"69","author":"JW Donaldson","year":"2014","unstructured":"Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW. The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study. Thorax. 2014;69:161\u20137.","journal-title":"Thorax."},{"key":"1386_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-weber syndrome). Am J Med Genet. 2000;91:66\u20137.","journal-title":"Am J Med Genet"},{"key":"1386_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13023-018-0850-2","volume":"13","author":"CL Shovlin","year":"2018","unstructured":"Shovlin CL, Buscarini E, Kjeldsen AD, Mager HJ, Sabba C, Droege F, Geisthoff U, Ugolini S, Dupuis-Girod S. European reference network for rare vascular diseases (VASCERN) outcome measures for hereditary Haemorrhagic telangiectasia (HHT). Orphanet J Rare Dis. 2018;13:136.","journal-title":"Orphanet J Rare Dis"},{"key":"1386_CR7","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1161\/STROKEAHA.114.007367","volume":"46","author":"H Kim","year":"2015","unstructured":"Kim H, Nelson J, Krings T, terBrugge KG, CE MC, Lawton MT, Young WL, Faughnan ME, Brain vascular malformation consortium HHT Investigator Group. Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Stroke. 2015;46:1362\u20134.","journal-title":"Stroke."},{"issue":"8","key":"1386_CR8","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3174\/ajnr.A4762","volume":"37","author":"W Brinjikji","year":"2016","unstructured":"Brinjikji W, Iyer VN, Yamaki V, Lanzino G, Cloft HJ, Thielen KR, Swanson KL, Wood CP. Neurovascular manifestations of hereditary hemorrhagic telangiectasia: a consecutive series of 376 patients during 15 years. AJNR Am J Neuroradiol. 2016;37(8):1479\u201386.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1386_CR9","unstructured":"Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO; 1968. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/37650\/WHO_PHP_34.pdf?sequence=17 (accessed 10th Feb 2020)."},{"key":"1386_CR10","unstructured":"Raffle A, Gray M. Screening. Evidence and practice: Oxford University Press; 2007. Oxford University Press. ISBN-10: 0199214492."},{"key":"#cr-split#-1386_CR11.1","doi-asserted-by":"crossref","unstructured":"Andermann A, Blancquaert I, Beauchamp S, D\u00e9ry V, Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years: Bull World Health Organ 2008: 86 (4)","DOI":"10.2471\/BLT.07.050112"},{"key":"#cr-split#-1386_CR11.2","unstructured":"241-320, https:\/\/www.who.int\/bulletin\/volumes\/86\/4\/07-050112\/en\/ (accessed 10th Feb 2020)."},{"key":"1386_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00234-005-1390-8","volume":"47","author":"T Krings","year":"2005","unstructured":"Krings T, Ozanne A, Chng SM, Alvarez H, Rodesch G, Lasjaunias PL. Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day-60 years. Neuroradiology. 2005;47:711\u201320.","journal-title":"Neuroradiology."},{"key":"1386_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3171\/2012.10.JNS121280","volume":"118","author":"BA Gross","year":"2013","unstructured":"Gross BA, Du R. Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg. 2013;118:437\u201343.","journal-title":"J Neurosurg"},{"key":"1386_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/neurintsurg-2015-012252","volume":"9","author":"W Brinjikji","year":"2017","unstructured":"Brinjikji W, Iyer VN, Lanzino G, Thielen KR, Wood CP. Natural history of brain capillary vascular malformations in hereditary hemorrhagic telangiectasia patients. J Neurointerv Surg. 2017;9:26\u20138.","journal-title":"J Neurointerv Surg"},{"key":"1386_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3174\/ajnr.A4210","volume":"36","author":"T Krings","year":"2015","unstructured":"Krings T, Kim H, Power S, Nelson J, Faughnan ME, Young WL, terBrugge KG, brain vascular malformation consortium HHT Investigator Group. Neurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations. AJNR Am J Neuroradiol. 2015;36:863\u201370.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1386_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1227\/NEU.0000000000001103","volume":"78","author":"W Yang","year":"2016","unstructured":"Yang W, Liu A, Hung AL, Braileanu M, Wang JY, Caplan JM, Colby GP, Coon AL, Tamargo RJ, Ahn ES, Huang J. Lower risk of intracranial arteriovenous malformation hemorrhage in patients with hereditary hemorrhagic telangiectasia. Neurosurgery. 2016;78:684.","journal-title":"Neurosurgery"},{"key":"1386_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S1474-4422(19)30231-5","volume":"18","author":"SM Zuurbier","year":"2019","unstructured":"Zuurbier SM, Hickman CR, Tolias CS, Rinkel LA, Leyrer R, Flemming KD, Bervini D, Lanzino G, Wityk RJ, Schneble HM, Sure U, Al-Shahi Salman R. Scottish Audit of Intracranial Vascular Malformations Steering Committee. Long-term Antithrombotic Therapy and Risk of Intracranial Haemorrhage From Cerebral Cavernous Malformations: A Population-Based Cohort Study, Systematic Review, and Meta-Analysis. Lancet Neurol. 2019;18:935\u201341.","journal-title":"Lancet Neurol"},{"key":"1386_CR18","doi-asserted-by":"crossref","unstructured":"Chen B, Herten A, Saban D, Rauscher S, Radbruch A, Schmidt B, Zhu Y, Jabbarli R, . Wrede KH, Kleinschnitz C, Sure U, Dammann P. Hemorrhage from cerebral cavernous malformations: the role of associated developmental venous anomalies. Neurology. 2020 in press..","DOI":"10.1212\/WNL.0000000000009730"},{"key":"1386_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3171\/2013.10.JNS122402","volume":"120","author":"MN Woodall","year":"2014","unstructured":"Woodall MN, McGettigan M, Figueroa R, Gossage JR, Alleyne CH Jr. Cerebral vascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg. 2014;120:87\u201392.","journal-title":"J Neurosurg"},{"key":"1386_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.5582\/irdr.2018.01103","volume":"7","author":"G Fatania","year":"2018","unstructured":"Fatania G, Gilson C, Glover A, Alsafi A, Jackson JE, Patel MC, Shovlin CL. Uptake and radiological findings of screening cerebral magnetic resonance scans in patients with hereditary haemorrhagic telangiectasia. Intractable Rare Dis Res. 2018;7:236\u201344.","journal-title":"Intractable Rare Dis Res"},{"key":"1386_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S1474-4422(11)70109-0","volume":"10","author":"MH Vlak","year":"2011","unstructured":"Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol. 2011;10:626\u201336.","journal-title":"Lancet Neurol"},{"key":"1386_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/jnnp.74.6.743","volume":"74","author":"AJ Easey","year":"2003","unstructured":"Easey AJ, Wallace GM, Hughes JM, Jackson JE, Taylor WJ, Shovlin CL. Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life. J Neurol Neurosurg Psychiatry. 2003;74:743\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1386_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/ane.12167","volume":"129","author":"AD Kjeldsen","year":"2014","unstructured":"Kjeldsen AD, T\u00f8rring PM, Nissen H, Andersen PE. Cerebral abscesses among Danish patients with hereditary haemorrhagic telangiectasia. Acta Neurol Scand. 2014;129:192\u20137.","journal-title":"Acta Neurol Scand"},{"key":"1386_CR24","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0000000000001369","volume":"79","author":"W Brinjikji","year":"2016","unstructured":"Brinjikji W, Lanzino G. Lower risk of intracranial arteriovenous malformation hemorrhage in patients with hereditary hemorrhagic telangiectasia. Neurosurgery. 2016;79:e944.","journal-title":"Neurosurgery."},{"key":"1386_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/B978-0-444-63640-9.00002-3","volume":"143","author":"A Can","year":"2017","unstructured":"Can A, Gross BA, Du R. The natural history of cerebral arteriovenous malformations. Handb Clin Neurol. 2017;143:15\u201324.","journal-title":"Handb Clin Neurol"},{"key":"1386_CR26","unstructured":"Osborn AG, Hedlund GL, Salzman KL. Osborn's Brain, 2nd edition. 2017 Elsevier (Philadelphia) ISBN 978\u20130\u2013323-47776-S."},{"key":"1386_CR27","first-page":"393","volume":"10","author":"VV Halbach","year":"1989","unstructured":"Halbach VV, Higashida RT, Hieshima GB, Wilson CB, Hardin CW, Kwan E. Treatment of dural fistulas involving the deep cerebral venous system. AJNR Am J Neuroradiol. 1989;10:393\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1386_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.wneu.2016.03.080","volume":"91","author":"P Dammann","year":"2016","unstructured":"Dammann P, Jabbarli R, Wittek P, Oppong MD, Kneist A, Zhu Y, Wrede K, M\u00fcller O, Forsting M, Sure U. Solitary sporadic cerebral cavernous malformations: risk factors of first or recurrent symptomatic hemorrhage and associated functional impairment. World Neurosurg. 2016;91:73\u201380.","journal-title":"World Neurosurg"},{"key":"1386_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/B978-0-444-63640-9.00025-4","volume":"143","author":"EM Cox","year":"2017","unstructured":"Cox EM, Bambakidis NC, Cohen ML. Pathology of cavernous malformations. Handb Clin Neurol. 2017;143:267\u201377.","journal-title":"Handb Clin Neurol"},{"key":"1386_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00234-007-0279-0","volume":"49","author":"D San Mill\u00e1n Ru\u00edz","year":"2007","unstructured":"San Mill\u00e1n Ru\u00edz D, Delavelle J, Yilmaz H, Gailloud P, Piovan E, Bertramello A, Pizzini F, R\u00fcfenacht DA. Parenchymal abnormalities associated with developmental venous anomalies. Neuroradiology. 2007;49:987\u201395.","journal-title":"Neuroradiology"},{"key":"1386_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-444-63640-9.00026-6","volume":"143","author":"MA Mooney","year":"2017","unstructured":"Mooney MA, Zabramski JM. Developmental venous anomalies. Handb Clin Neurol. 2017;143:279\u201382.","journal-title":"Handb Clin Neurol"},{"key":"1386_CR32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.neurol.2008.07.012","volume":"164","author":"GJ Rinkel","year":"2008","unstructured":"Rinkel GJ. Natural history, epidemiology and screening of unruptured intracranial aneurysms. Rev Neurol (Paris). 2008;164:781\u20136.","journal-title":"Rev Neurol (Paris)"},{"key":"1386_CR33","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1378\/chest.13-0716","volume":"144","author":"S Velthuis","year":"2013","unstructured":"Velthuis S, Vorselaars VMM, van Gent MWF, Westermann CJJ, Snijder RJ, Mager JJ, Post MC. Role of transthoracic contrast echocardiography in the clinical diagnosis of hereditary hemorrhagic telangiectasia. Chest. 2013;144:1876\u201382.","journal-title":"Chest."},{"key":"1386_CR34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3171\/jns.2000.92.5.0779","volume":"92","author":"RB Willemse","year":"2000","unstructured":"Willemse RB, Mager JJ, Westermann CJ, Overtoom TT, Mauser H, Wolbers JG. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg. 2000;92:779\u201384.","journal-title":"J Neurosurg"},{"key":"1386_CR35","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00701-017-3154-8","volume":"159","author":"M Cenzato","year":"2017","unstructured":"Cenzato M, Boccardi E, Beghi E, Vajkoczy P, Szikora I, Motti E, Regli L, Raabe A, Eliava S, Gruber A, Meling TR, Niemela M, Pasqualin A, Golanov A, Karlsson B, Kemeny A, Liscak R, Lippitz B, Radatz M, La Camera A, Chapot R, Islak C, Spelle L, Debernardi A, Agostoni E, Revay M, Morgan MK. European consensus conference on unruptured brain AVMs treatment. Acta Neurochir. 2017;159:1059\u201364.","journal-title":"Acta Neurochir"},{"key":"1386_CR36","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0140-6736(13)62302-8","volume":"383","author":"JP Mohr","year":"2014","unstructured":"Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, Al-Shahi Salman R, Vicaut E, Young WL, Houdart E, Cordonnier C, Stefani MA, Hartmann A, von Kummer R, Biondi A, Berkefeld J, Klijn CJ, Harkness K, Libman R, Barreau X, Moskowitz AJ, international ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383:614.","journal-title":"Lancet"},{"key":"1386_CR37","first-page":"1016","volume":"21","author":"S Matsubara","year":"2000","unstructured":"Matsubara S, Mandzia JL, ter Brugge K, Willinsky RA, Faughnan ME. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol. 2000;21:1016\u201320.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1386_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF00589113","volume":"32","author":"RA Willinsky","year":"1990","unstructured":"Willinsky RA, Lasjaunias P, Terbrugge K, Burrows P. Multiple cerebral arteriovenous malformations (AVMs). Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology. 1990;32:207\u201310.","journal-title":"Neuroradiology."},{"key":"1386_CR39","doi-asserted-by":"publisher","first-page":"b5400","DOI":"10.1136\/bmj.b5400","volume":"340","author":"L Dauwerse","year":"2010","unstructured":"Dauwerse L, Abma TA, Wolbers JG. A patient's journey: the war in my head: coping with arteriovenous malformation after a brain haemorrhage. BMJ. 2010;340:b5400.","journal-title":"BMJ"},{"key":"1386_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2796.2005.01555.x","volume":"258","author":"AD Kjeldsen","year":"2005","unstructured":"Kjeldsen AD, M\u00f8ller TR, Brusgaard K, Vase P, Andersen PE. Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia. J Int Med. 2005;258:349\u201355.","journal-title":"J Int Med"},{"key":"1386_CR41","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/jmg.2005.035451","volume":"43","author":"TG Letteboer","year":"2006","unstructured":"Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, Westermann CJ. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet. 2006;43:371\u20137.","journal-title":"J Med Genet"},{"key":"1386_CR42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/humu.20342","volume":"27","author":"AD Bossler","year":"2006","unstructured":"Bossler AD, Richards J, George C, Godmilow L, Ganguly A. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype. Hum Mutat. 2006;27:667\u201375.","journal-title":"Hum Mutat"},{"key":"1386_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/GIM.0b013e31802d8373","volume":"9","author":"G Lesca","year":"2007","unstructured":"Lesca G, Olivieri C, Burnichon N, Pagella F, Carette MF, Gilbert-Dussardier B, Goizet C, Roume J, Rabilloud M, Saurin JC, Cottin V, Honnorat J, Coulet F, Giraud S, Calender A, Danesino C, Buscarini E, Plauchu H, French-Italian-Rendu-Osler network. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med. 2007;9:14\u201322.","journal-title":"Genet Med"},{"key":"1386_CR44","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1538-7836.2007.02531.x","volume":"5","author":"C Sabb\u00e0","year":"2007","unstructured":"Sabb\u00e0 C, Pasculli G, Lenato GM, Suppressa P, Lastella P, Memeo M, Dicuonzo F, Guant G. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost. 2007;5:1149\u20135.","journal-title":"J Thromb Haemost"},{"key":"1386_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jpeds.2013.02.009","volume":"163","author":"P Giordano","year":"2013","unstructured":"Giordano P, Lenato GM, Suppressa P, Lastella P, Dicuonzo F, Chiumarulo L, Sangerardi M, Piccarreta P, Valerio R, Scardapane A, Marano G, Resta N, Quaranta N, Sabb\u00e0 C. Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. J Pediatr. 2013;163:179\u201386 e1\u20133.","journal-title":"J Pediatr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01386-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01386-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01386-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:18:47Z","timestamp":1624925927000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01386-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01386-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approvals in place at each VASCERN center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}